Atom Investors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,063
| Closed | -$38K | – | 593 |
|
|
2024
Q4 | $38K | Buy |
1,063
+77
| +8% | +$2.75K | ﹤0.01% | 475 |
|
|
2024
Q3 | $46.6K | Sell |
986
-13,631
| -93% | -$644K | ﹤0.01% | 450 |
|
|
2024
Q2 | $735K | Sell |
14,617
-2,952
| -17% | -$148K | 0.07% | 286 |
|
|
2024
Q1 | $1.97M | Sell |
17,569
-13,417
| -43% | -$1.5M | 0.25% | 133 |
|
|
2023
Q4 | $1.8M | Buy |
30,986
+19,259
| +164% | +$1.12M | 0.32% | 107 |
|
|
2023
Q3 | $372K | Buy |
+11,727
| New | +$372K | 0.08% | 280 |
|
|
2022
Q4 | – | Sell |
-1,004
| Closed | -$170K | – | 282 |
|
|
2022
Q3 | $170K | Buy |
+1,004
| New | +$170K | 0.06% | 222 |
|
|
2021
Q1 | – | Sell |
-15,165
| Closed | -$10.1M | – | 357 |
|
|
2020
Q4 | $10.1M | Buy |
15,165
+941
| +7% | +$626K | 1.02% | 24 |
|
|
2020
Q3 | $6.62M | Buy |
14,224
+11,538
| +430% | +$5.37M | 0.63% | 30 |
|
|
2020
Q2 | $1.57M | Buy |
+2,686
| New | +$1.57M | 0.1% | 153 |
|